Prophylaxis (TB)

Hepatotoxicity is Real Problem with Isoniazid

Published in TB and Outbreaks Week, May 3rd, 1999

Monthly liver function testing is critical in anyone receiving isoniazid for the prevention of tuberculosis, according to an Australian report.

Researchers from Victoria's Monash Medical Center found the incidence of hepatotoxicity to be significant in a group of healthcare workers who were receiving prophylaxis with isoniazid.

"Preventive therapy with isoniazid has an important role, and guidelines for such therapy have been defined," Rhonda L. Stuart and colleagues wrote ("Isoniazid Toxicity in Healthcare Workers," Clinical Infectious Diseases, April 1999;28:895-897).

"Nevertheless, the relatively high rate of symptomatic and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1999-05-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry